感染是粒细胞减少病人发病和死亡的主要原因。新抗菌素的应用确已使这些病人的予后有所改观,但大多数药物对粒细胞减少无明显效果。因此对粒细胞减少伴感染病人输入粒细胞是合理的,在动物实验中已证明输入粒细胞有效。作者对于有粒细胞减少并发感染的白血病病人进行了随机研究,以评价粒细胞输入疗法的临床疗效。 Infection is the leading cause of morbidity and mortality in patients with neutropenia. The use of new antibiotics has indeed improved the prognosis of these patients, but most drugs have no significant effect on neutropenia. Therefore, granulocytopenia patients infected with the import of granulocytes is reasonable in animal experiments have proved that the import of granulocytes effective. The authors conducted a randomized study of leukemia patients with concurrent neutropenia to evaluate the clinical efficacy of granulocyte-entry therapy.